Insider Transactions Reported by 24 Insiders of Humacyte, Inc.

Symbol
HUMA, HUMAW on Nasdaq
Location
Durham, NC

Insiders trading volume in the past year

Humacyte, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ Former 10% Shareholder $21,792,154 26 Aug 2021
Ayabudge LLC 10%+ Owner $9,747,457 17 Aug 2023
Laura E. Niklason President, CEO and Director, Director $3,382,780 -$3,733,191 -52% 16 Nov 2025
Brady W. Dougan Director $3,382,780 -$3,733,191 -52% 16 Nov 2025
Gordon M. Binder Director $1,413,300 15 May 2024
Dale A. Sander CFO and Chief Corp. Deve. Off. $604,827 +$30,600 +5.3% 16 Nov 2025
Shamik J. Parikh Chief Medical Officer $544,806 +$11,625 +2.2% 16 Nov 2025
Kathleen Sebelius Director $120,393 +$66,000 +121% 12 Jun 2025
William Edward Tente Chief Regulatory Officer $62,498 26 Aug 2021
Constantino Michael T. Director $41,517 +$20,160 +94% 12 Jun 2025
William John Scheessele Chief Commercial Officer $33,908 +$9,999 +42% 14 Apr 2025
Charles Bruce Green Director $10,836 +$7,740 +250% 12 Jun 2025
Jeffrey Harold Lawson Chief Surgical Officer, Director $9,374 26 Aug 2021
Heather Ledbetter Prichard Chief Operating Officer $0 21 Jan 2025
Emery N. Brown Director 12 Jun 2025
Max N. Wallace Director 12 Jun 2025
Todd Pope Director 12 Jun 2025
Rajiv Shukla Director 15 Jun 2023
Diane Seimetz Director 12 Jun 2025
Yang Cao Chief Regulatory Officer 21 Jan 2025
Kiernan Thomas DeAngelis Chief Medical Officer 26 Aug 2021
Richards Windham Bannister Director 12 Jun 2025
Keith Anthony Jones Director 12 Jun 2025
John Philip Bamforth Director 12 Jun 2025

Recent Insider Transactions by Companies or Individuals for Humacyte, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.